Month: September 2022

Luminor Bank has granted short-term loans to AB Linas Agro Group and twelve subsidiaries for a total amount of EUR 118 million. The latest agreement on a EUR 7 million loan between Luminor and UAB Linas Agro Konsultacijos was signed last Friday, 23 September. ‘Since the spring, we have increased the Group’s total short-term financing with Luminor Bank by EUR 35.5 million. The need for working capital is growing not only in food production but also in other areas, such as trade in feed raw materials and the activities of agricultural companies. Completely changed supply markets and logistics, the growth of energy prices, and the planned expansion of activities also increase the need for working capital,’ says Mažvydas Šileika, CFO of Linas Agro Group. The bank’s financing is intended for the Group’s working capital. The...

Basel, 26 September 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Julie Brown has notified the Board that she will step down as a member of the Roche Board of Directors as she has accepted a management role at another pharmaceutical company. This change will be effective from today. Ms. Brown was elected to the Board of Directors in March 2016 and has since been the Chairwoman of the Audit Committee. Dr. Patrick Frost will chair the Audit Committee on an interim basis until the Annual General Meeting in March 2023. Roche Chairman Christoph Franz: “As a Board member and Chairwoman of the Audit Committee, Julie Brown has contributed significantly to Roche’s success. On behalf of the Board, I would like to express our sincere thanks for Julie’s commitment and contributions to Roche and wish her all the best for...

TORONTO, Sept. 25, 2022 (GLOBE NEWSWIRE) — Abaxx Technologies Inc., (NEO: ABXX) (OTCQX: ABXXF) (“Abaxx” or the “Company”), a financial software company, majority shareholder of Abaxx Singapore Pte. Ltd., the Abaxx Commodity Exchange (ACX), announces SmarterMarkets™, its media platform producing a weekly podcast focused on redesigning markets and technology to better serve society, has surpassed 1 million downloads. Highlights:SmarterMarkets™ passes 1 million downloads milestone 72% of podcast listeners are Director level or above at their organization 55% of listeners work in the Energy, Financial Services and Technology sectorsSeries content features entrepreneurs, icons, and executives of commodities, capital markets, and technology ranting on the inadequacies of our systems and riffing on ideas to improve them.  The podcast...

Orphazyme A/SCompany announcement No. 35/2022                         www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, September 25, 2022 – Orphazyme A/S (ORPHA.CO) (the “Company”) has decided to adjust its outlook for 2022, as published on June 7, 2022. The change is driven by the separation of activities into continuing and discontinued operations. The discontinued activities are related to the sale of assets to KemPharm A/S. The continuing business activities are the limited ongoing operational business activities with only two employees. For the full-year 2022, we anticipate a loss from continuing operations in the range DKK 40 – 45 million and a positive result from discontinued operations relating to the Sale of Assets to KemPharm of DKK 87.4 million (previously operating profit in the range DKK 10 – 30 million)....

VANCOUVER, Sept. 25, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, announces that it will be consolidating all of the issued and outstanding common shares of the Company (“Common Shares“) on the basis of one (1) post consolidation Common Share for each thirty (30) pre consolidation Common Shares (the “Consolidation“). The Corporation’s board of directors set September 30, 2022 as the effective date of the Consolidation. Trading of the Common Shares on a post-Consolidation basis on the Canadian Securities Exchange (the “CSE“) will commence on or about October...

Logent Group continue to grow into new markets and expects to shortly establish operations in the Netherlands. Logent Group is in advanced negotiations with NA-KD regarding a first partnership whereby the strategic partnership with Logent Group is strengthened. It is a strategic decision to establish operations at one of the largest logistics markets in Europe. It will provide us a solid base for further growth in Europe and will offer both existing and new customers new opportunities, says Mats Steen, CEO Logent Group. Logent Group is in final negotiations with NA-KD to strengthen the strategic partnership with Logent Group. Logent Group will thereby be selected as logistics partner and the parties intend to soon sign a five-year cooperation agreement. Pursuant to the cooperation agreement which is being negotiated, Logent Group will...

VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) announces that it has filed a technical report (the “Technical Report”) containing a maiden resource estimate on the Blue Lake gold-copper porphyry deposit in Papua New Guinea. The Technical Report, titled, “Independent Technical Report, Mineral Resource Estimate Blue Lake Porphyry Deposit, Kainantu, Papua New Guinea” dated September 20, 2022, with an effective date of August 1, 2022, was prepared by Simon Tear BSc (Hons), EurGeol, PGeo IGI, EurGeol, and Anthony Woodward BSc (Hons), M.Sc., MAIG. Refer to the Company’s news release dated August 9, 2022, for a summary of the key results, assumptions and estimates contained in the Technical Report. The Technical Report was prepared in accordance with National...

TEL AVIV, Israel, Sept. 23, 2022 (GLOBE NEWSWIRE) — REE Automotive Ltd. (NASDAQ: REE) (“REE” or the “Company”), an automotive technology leader and provider of electric vehicle (EV) platforms, announced today the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding (i) public warrants to purchase Class A ordinary shares of the Company, without par value (the “Class A ordinary shares”), which warrants trade on the Nasdaq Stock Market (“Nasdaq”) under the symbol “REEAW” (the “public warrants”), and (ii) related private placement warrants to purchase Class A ordinary shares (the “private placement warrants” and, together with the public warrants, the Warrants”). The Offer and Consent Solicitation expired at midnight (end of...